Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA

Molecular Therapy - Oncolytics - Tập 24 - Trang 742-754 - 2022
Shuilian Wu1, Haotian Xu2,3, Ruirui Zhang2,3,1, Xin Wang1, Jialei Yang3, Xiaofei Li2,3, Sixian Chen2,3, Wanting He3, Aruo Nan2,3,1
1Zhejiang Provincial Key Laboratory for Technology and Application of Model Organisms, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
2Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China
3Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, Guangxi, China

Tài liệu tham khảo

Siegel, 2019, Cancer statistics, 2019, CA Cancer J. Clin., 69, 7, 10.3322/caac.21551 Keck, 2011, The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma, Int. J. Cancer, 129, 346, 10.1002/ijc.25700 Grayson, 2017, Bladder cancer, Nature, 551, S33, 10.1038/551S33a Xiao, 2018, Circ008913, via miR-889 regulation of DAB2IP/ZEB1, is involved in the arsenite-induced acquisition of CSC-like properties by human keratinocytes in carcinogenesis, Metallomics, 10, 1328, 10.1039/C8MT00207J Berrout, 2017, TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p, Nat. Commun., 8, 947, 10.1038/s41467-017-00983-w Xiao, 2020, Targeting the estrogen receptor alpha (ERalpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion, Oncogene, 39, 2493, 10.1038/s41388-019-1150-6 Kristensen, 2018, Circular RNAs in cancer: opportunities and challenges in the field, Oncogene, 37, 555, 10.1038/onc.2017.361 Meng, 2017, CircRNA: functions and properties of a novel potential biomarker for cancer, Mol. Cancer, 16, 94, 10.1186/s12943-017-0663-2 Wang, 2019, Changing expression profiles of mRNA, lncRNA, circRNA, and miRNA in lung tissue reveal the pathophysiological of bronchopulmonary dysplasia (BPD) in mouse model, J. Cell. Biochem., 120, 9369, 10.1002/jcb.28212 Jian, 2020, Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340, Mol. Cancer, 19, 20, 10.1186/s12943-020-1134-8 Guan, 2019, Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data, Cancer Cell Int., 19, 183, 10.1186/s12935-019-0905-z Li, 2017, Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance, Dis. Markers, 2017, 4587698, 10.1155/2017/4587698 Li, 2015, Using circular RNA as a novel type of biomarker in the screening of gastric cancer, Clin. Chim. Acta, 444, 132, 10.1016/j.cca.2015.02.018 Fu, 2017, Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma, Oncotarget, 8, 58405, 10.18632/oncotarget.16881 Zheng, 2016, Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs, Nat. Commun., 7, 11215, 10.1038/ncomms11215 Nan, 2019, Circular RNA circNOL10 inhibits lung cancer development by promoting SCLM1-mediated transcriptional regulation of the humanin polypeptide family, Adv. Sci. (Weinh), 6, 1800654, 10.1002/advs.201800654 Lu, 2017, Roles of the circular RNA circ-Foxo3 in breast cancer progression, Cell Cycle, 16, 589, 10.1080/15384101.2017.1278935 Khleif, 1996, Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity, Proc. Natl. Acad. Sci. U S A, 93, 4350, 10.1073/pnas.93.9.4350 Barrios, 2015, Expanding the Iroquois genes repertoire: a non-transcriptional function in cell cycle progression, Fly (Austin), 9, 126, 10.1080/19336934.2016.1139654 Li, 2017, The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches, Oncotarget, 8, 33225, 10.18632/oncotarget.16600 Sun, 2017, Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: a meta-analysis, Medicine (Baltimore), 96, e6860, 10.1097/MD.0000000000006860 Woo, 2008, Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma, Pediatr. Blood Cancer, 50, 208, 10.1002/pbc.21195 Yang, 2015, Transcriptome analysis of human OXR1 depleted cells reveals its role in regulating the p53 signaling pathway, Sci. Rep., 5, 17409, 10.1038/srep17409 Qiu, 2018, The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma, Cancer Res., 78, 2839, 10.1158/0008-5472.CAN-17-2808 Xue, 2017, Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 753, 10.1016/j.bbadis.2016.12.018 Ma, 2018, Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via miR-1275/FOXK1 axis, Biochem. Biophys. Res. Commun., 498, 1009, 10.1016/j.bbrc.2018.03.105 Zhang, 2018, CircRNA: a novel type of biomarker for cancer, Breast Cancer, 25, 1, 10.1007/s12282-017-0793-9 Feng, 2019, Genome-wide identification of cancer-specific alternative splicing in circRNA, Mol. Cancer, 18, 35, 10.1186/s12943-019-0996-0 Hansen, 2013, Circular RNA and miR-7 in cancer, Cancer Res., 73, 5609, 10.1158/0008-5472.CAN-13-1568 Liu, 2019, Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p, Cell Death Dis., 10, 55, 10.1038/s41419-018-1287-1 Zhu, 2019, Circular RNA hsa_circ_0007142 is upregulated and targets miR-103a-2-5p in colorectal cancer, J. Oncol., 2019, 9836819 Ghizoni, 2020, The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker, Clin. Transl. Oncol., 22, 804, 10.1007/s12094-019-02210-y Chipumuro, 2014, CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer, Cell, 159, 1126, 10.1016/j.cell.2014.10.024 Wang, 2017, JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer, Oncotarget, 8, 86312, 10.18632/oncotarget.21146 Qin, 2018, Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid, Proc. Natl. Acad. Sci. U S A, 115, 4969, 10.1073/pnas.1802279115 Hossain, 2012, NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo, Cancer Res., 72, 4587, 10.1158/0008-5472.CAN-12-0943 Tong, 2019, MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis, Am. J. Cancer Res., 9, 1938 Zhang, 2018, Targeting the MYCN-PARP-DNA damage response pathway in neuroendocrine prostate cancer, Clin. Cancer Res., 24, 696, 10.1158/1078-0432.CCR-17-1872 Hansel, 2008, HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases, Am. J. Clin. Pathol., 130, 274, 10.1309/41VLTFX3YPP1HF6F Sarma, 2017, p16INK4a expression in cervical lesions correlates with histologic grading - a tertiary level medical facility based retrospective study, Asian Pac. J. Cancer Prev., 18, 2643